- Home
- ONC vs ALC Comparison
ONC vs ALC Comparison
Compare ONC & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- ALC
- Stock Information
- Founded
- ONC 2010
- ALC 1945
- Country
- ONC Switzerland
- ALC Switzerland
- Employees
- ONC N/A
- ALC N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- ALC Ophthalmic Goods
- Sector
- ONC Health Care
- ALC Health Care
- Exchange
- ONC Nasdaq
- ALC Nasdaq
- Market Cap
- ONC 37.2B
- ALC 43.2B
- IPO Year
- ONC N/A
- ALC N/A
- Fundamental
- Price
- ONC $313.67
- ALC $82.00
- Analyst Decision
- ONC Strong Buy
- ALC Buy
- Analyst Count
- ONC 9
- ALC 12
- Target Price
- ONC $335.78
- ALC $98.05
- AVG Volume (30 Days)
- ONC 410.3K
- ALC 2.3M
- Earning Date
- ONC 08-06-2025
- ALC 08-19-2025
- Dividend Yield
- ONC N/A
- ALC 0.26%
- EPS Growth
- ONC N/A
- ALC N/A
- EPS
- ONC N/A
- ALC 2.16
- Revenue
- ONC $4,562,002,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- ONC $865.19
- ALC $6.75
- Revenue Next Year
- ONC $21.12
- ALC $7.60
- P/E Ratio
- ONC N/A
- ALC $37.87
- Revenue Growth
- ONC 47.33
- ALC 4.04
- 52 Week Low
- ONC $170.99
- ALC $78.11
- 52 Week High
- ONC $330.63
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- ONC 61.68
- ALC 40.40
- Support Level
- ONC $301.33
- ALC $78.11
- Resistance Level
- ONC $330.63
- ALC $90.41
- Average True Range (ATR)
- ONC 9.12
- ALC 1.58
- MACD
- ONC -0.19
- ALC -0.61
- Stochastic Oscillator
- ONC 66.43
- ALC 31.63
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.